Cargando…

Levels of brain‐derived neurotrophic factor in patients with multiple sclerosis

OBJECTIVE: To determine the levels of brain‐derived neurotrophic factor (BDNF) in the serum of patients suffering from multiple sclerosis (MS) to evaluate the potential of serum BDNF as a biomarker for MS. METHODS: Using a recently validated enzyme‐linked immunoassay (ELISA) we measured BDNF in pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naegelin, Yvonne, Saeuberli, Katharina, Schaedelin, Sabine, Dingsdale, Hayley, Magon, Stefano, Baranzini, Sergio, Amann, Michael, Parmar, Katrin, Tsagkas, Charidimos, Calabrese, Pasquale, Penner, Iris Katharina, Kappos, Ludwig, Barde, Yves‐Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664260/ https://www.ncbi.nlm.nih.gov/pubmed/33031634 http://dx.doi.org/10.1002/acn3.51215

Ejemplares similares

Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum
por: Naegelin, Yvonne, et al.
Publicado: (2018)

Longitudinal patterns of cortical thinning in multiple sclerosis
por: Tsagkas, Charidimos, et al.
Publicado: (2020)

Regional Cerebellar Volume Loss Predicts Future Disability in Multiple Sclerosis Patients
por: Parmar, Katrin, et al.
Publicado: (2021)

Longitudinal changes of deep gray matter shape in multiple sclerosis
por: Tsagkas, Charidimos, et al.
Publicado: (2022)

Central nervous system atrophy predicts future dynamics of disability progression in a real‐world multiple sclerosis cohort
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Cerebellar Abnormalities Contribute to Disability Including Cognitive Impairment in Multiple Sclerosis
por: Weier, Katrin, et al.
Publicado: (2014)

Fingolimod in children with Rett syndrome: the FINGORETT study
por: Naegelin, Yvonne, et al.
Publicado: (2021)

Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)
por: Collongues, Nicolas, et al.
Publicado: (2020)

Additive and interaction effects of working memory and motor sequence training on brain functional connectivity
por: Zuber, Priska, et al.
Publicado: (2021)

Hepatitis E virus infections in patients with MS on oral disease-modifying treatment
por: Diebold, Martin, et al.
Publicado: (2019)

The placenta protects the fetal circulation from anxiety-driven elevations in maternal serum levels of brain-derived neurotrophic factor
por: Dingsdale, Hayley, et al.
Publicado: (2021)

Brain-derived Neurotrophic Factor in Megakaryocytes
por: Chacón-Fernández, Pedro, et al.
Publicado: (2016)

Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach
por: Hubacher, Martina, et al.
Publicado: (2015)

Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing‐remitting multiple sclerosis
por: Langdon, Dawn W., et al.
Publicado: (2021)

Death Anxiety and Attitudes towards Death in Patients with Multiple Sclerosis: An Exploratory Study
por: Francalancia, Jara, et al.
Publicado: (2021)

Assessment of cognitive performance in multiple sclerosis using smartphone-based training games: a feasibility study
por: Pless, Silvan, et al.
Publicado: (2023)

Reliability and acceptance of dreaMS, a software application for people with multiple sclerosis: a feasibility study
por: Woelfle, Tim, et al.
Publicado: (2022)

White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study
por: Magon, Stefano, et al.
Publicado: (2014)

Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis
por: Cagol, Alessandro, et al.
Publicado: (2023)

Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study
por: Fox, Jan, et al.
Publicado: (2016)

Leptomeningeal enhancement in multiple sclerosis and other neurological diseases: A systematic review and Meta-Analysis
por: Ineichen, Benjamin V., et al.
Publicado: (2022)

Practice Effects of Mobile Tests of Cognition, Dexterity, and Mobility on Patients With Multiple Sclerosis: Data Analysis of a Smartphone-Based Observational Study
por: Woelfle, Tim, et al.
Publicado: (2021)

Growth differentiation factor 15 is increased in stable MS
por: Amstad, Andrea, et al.
Publicado: (2020)

Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and Perspective
por: Woelfle, Tim, et al.
Publicado: (2023)

Brain atrophy measurement over a MRI scanner change in multiple sclerosis
por: Sinnecker, Tim, et al.
Publicado: (2022)

Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis
por: Gschwind, Markus, et al.
Publicado: (2016)

Cord serum brain-derived neurotrophic factor levels at birth associate with temperament outcomes at one year
por: Dingsdale, Hayley, et al.
Publicado: (2022)

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis
por: Penner, Iris-Katharina, et al.
Publicado: (2012)

Brain-derived neurotrophic factor measurements in mouse serum and plasma using a sensitive and specific enzyme-linked immunosorbent assay
por: Want, Andrew, et al.
Publicado: (2023)

An investigation of the association between focal damage and global network properties in cognitively impaired and cognitively preserved patients with multiple sclerosis
por: Wenger, A. L., et al.
Publicado: (2023)

Monitoring of radiologic disease activity by serum neurofilaments in MS
por: Uher, Tomas, et al.
Publicado: (2020)

Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two Cases
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Brain‐derived neurotrophic factor prevents dendritic retraction of adult mouse retinal ganglion cells
por: Binley, Kate E., et al.
Publicado: (2016)

Changes in the Cerebrospinal Fluid and Plasma Lipidome in Patients with Rett Syndrome
por: Zandl-Lang, Martina, et al.
Publicado: (2022)

Working Memory Training in Patients with Chronic Schizophrenia: A Pilot Study
por: Hubacher, Martina, et al.
Publicado: (2013)

Improved Characterization of Visual Evoked Potentials in Multiple Sclerosis by Topographic Analysis
por: Hardmeier, Martin, et al.
Publicado: (2013)

Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis
por: Müller, Jannis, et al.
Publicado: (2022)

Brain-derived neurotrophic factor released from blood platelets prevents dendritic atrophy of lesioned adult central nervous system neurons
por: Want, Andrew, et al.
Publicado: (2023)

Efficacy and Safety of Fingolimod in an Unselected Patient Population
por: Rasenack, Maria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ngkqja7ap80btmf5car2at9nvg